Neuroendocrine Differentiation in Lung Carcinoma

Overview

Journal Thorax

Date 1995 Feb 1

PMID 7701446

Citations 2

Authors

B J Addis

Affiliations

Soon will be listed here.

Citing Articles

Effective lung cancer control: An unaccomplished challenge in cancer research.

Panakkal N, Lekshmi A, Saraswathy V, Sujathan K Cytojournal. 2023; 20:16.

PMID: 37681073 PMC: 10481856. DOI: 10.25259/Cytojournal_36_2022.

Immunohistochemistry for assessment of pulmonary and pleural neoplasms: a review and update.

Tan D, Zander D Int J Clin Exp Pathol. 2008; 1(1):19-31.

PMID: 18784820 PMC: 2480532.

References

Kayser K, Schmid W, Ebert W, Wiedenmann B . Expression of neuroendocrine markers (neuronspecific enolase, synaptophysin and bombesin) in carcinoma of the lung. Pathol Res Pract. 1988; 183(4):412-7. DOI: 10.1016/S0344-0338(88)80087-6. View

Hamid Q, Addis B, Springall D, Ibrahim N, Ghatei M, Bloom S . Expression of the C-terminal peptide of human pro-bombesin in 361 lung endocrine tumours, a reliable marker and possible prognostic indicator for small cell carcinoma. Virchows Arch A Pathol Anat Histopathol. 1987; 411(2):185-92. DOI: 10.1007/BF00712743. View

Linnoila R, Mulshine J, Steinberg S, Funa K, Matthews M, Cotelingam J . Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas. Am J Clin Pathol. 1988; 90(6):641-52. DOI: 10.1093/ajcp/90.6.641. View

Hoog A, Gould V, Grimelius L, Franke W, Falkmer S, Chejfec G . Tissue fixation methods alter the immunohistochemical demonstrability of synaptophysin. Ultrastruct Pathol. 1988; 12(6):673-8. DOI: 10.3109/01913128809056493. View

Graziano S, Mazid R, Newman N, Tatum A, OLER A, Mortimer J . The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer. J Clin Oncol. 1989; 7(10):1398-406. DOI: 10.1200/JCO.1989.7.10.1398. View

Kibbelaar R, Moolenaar C, Michalides R, Bitter-Suermann D, Addis B, Mooi W . Expression of the embryonal neural cell adhesion molecule N-CAM in lung carcinoma. Diagnostic usefulness of monoclonal antibody 735 for the distinction between small cell lung cancer and non-small cell lung cancer. J Pathol. 1989; 159(1):23-8. DOI: 10.1002/path.1711590108. View

Hamid Q, Corrin B, Dewar A, Hoefler H, Sheppard M . Expression of gastrin-releasing peptide (human bombesin) gene in large cell undifferentiated carcinoma of the lung. J Pathol. 1990; 161(2):145-51. DOI: 10.1002/path.1711610209. View

Travis W, Linnoila R, Tsokos M, Hitchcock C, Cutler Jr G, Nieman L . Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol. 1991; 15(6):529-53. DOI: 10.1097/00000478-199106000-00003. View

Hamid Q, Corrin B, Sheppard M, Huttner W, Polak J . Expression of chromogranin A mRNA in small cell carcinoma of the lung. J Pathol. 1991; 163(4):293-7. DOI: 10.1002/path.1711630405. View

10.

Sundaresan V, Reeve J, Stenning S, Stewart S, Bleehen N . Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours. Br J Cancer. 1991; 64(2):333-8. PMC: 1977503. DOI: 10.1038/bjc.1991.301. View

11.

Sheppard M . Neuroendocrine differentiation in lung tumours. Thorax. 1991; 46(11):843-50. PMC: 1021042. DOI: 10.1136/thx.46.11.843. View

12.

Brambilla E, Veale D, Moro D, Morel F, Dubois F, Brambilla C . Neuroendocrine phenotype in lung cancers. Comparison of immunohistochemistry with biochemical determination of enolase isoenzymes. Am J Clin Pathol. 1992; 98(1):88-97. DOI: 10.1093/ajcp/98.1.88. View

13.

Aguayo S, Miller Y, Waldron Jr J, Bogin R, Sunday M, Staton Jr G . Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. N Engl J Med. 1992; 327(18):1285-8. DOI: 10.1056/NEJM199210293271806. View

14.

Lloyd R, Jin L, Kulig E, Fields K . Molecular approaches for the analysis of chromogranins and secretogranins. Diagn Mol Pathol. 1992; 1(1):2-15. DOI: 10.1097/00019606-199203000-00002. View

15.

Gosney J, Gosney M, Lye M, Butt S . Reliability of commercially available immunocytochemical markers for identification of neuroendocrine differentiation in bronchoscopic biopsies of bronchial carcinoma. Thorax. 1995; 50(2):116-20. PMC: 473891. DOI: 10.1136/thx.50.2.116. View

16.

Addis B, Hamid Q, Ibrahim N, Fahey M, Bloom S, Polak J . Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumours of the lung. J Pathol. 1987; 153(2):137-50. DOI: 10.1002/path.1711530207. View

17.

Bensch K, Corrin B, Pariente R, Spencer H . Oat-cell carcinoma of the lung. Its origin and relationship to bronchial carcinoid. Cancer. 1968; 22(6):1163-72. DOI: 10.1002/1097-0142(196811)22:6<1163::aid-cncr2820220612>3.0.co;2-l. View

18.

Gazdar A, Zweig M, Carney D, Van Steirteghen A, Baylin S, Minna J . Levels of creatine kinase and its BB isoenzyme in lung cancer specimens and cultures. Cancer Res. 1981; 41(7):2773-7. View

19.

Cutz E . Neuroendocrine cells of the lung. An overview of morphologic characteristics and development. Exp Lung Res. 1982; 3(3-4):185-208. DOI: 10.3109/01902148209069653. View

20.

Gould V, Linnoila R, Memoli V, Warren W . Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms. Lab Invest. 1983; 49(5):519-37. View